BioArctic AB (publ) (BIOA-B) — Cash Flow Reinvestment Rate

Latest as of June 2025: 1.65x

BioArctic AB (publ) (BIOA-B) has a Cash Flow Reinvestment Rate of 1.65x as of June 2025, reinvesting Skr1.89 Billion (capex Skr1.15 Billion plus investments Skr-742.91 Million) from operating cash flow of Skr1.15 Billion. Explore BioArctic AB (publ) (BIOA-B) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.65x
(Capex + Investments) / Operating CF

Total Reinvested

Skr1.89 Billion
Capex + Investments

Operating Cash Flow

Skr1.15 Billion
SEK

Capital Expenditures

Skr1.15 Billion
SEK

BioArctic AB (publ) Cash Flow Reinvestment Rate (2016–2023)

Historical reinvestment intensity for BioArctic AB (publ) across 3 annual periods. Also explore BIOA-B current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BioArctic AB (publ) (2016–2023)

Year-by-year capital reinvestment analysis for BioArctic AB (publ). For live market cap and broader valuation context, see BioArctic AB (publ) stock valuation.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2023 1.01x Skr314.00 Million Skr309.69 Million Skr7.44 Million ▲ +10035.0%
2019 0.01x Skr3.27 Million Skr327.17 Million Skr3.26 Million ▲ +13.7%
2016 0.01x Skr5.94 Million Skr675.13 Million Skr2.97 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow